Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
A recent study conducted by the Atopic Dermatitis Research Network aimed to identify the historical, clinical, and biomarker determinants associated with the severity of atopic dermatitis.
A recent study conducted by the Atopic Dermatitis Research Network aimed to identify the historical, clinical, and biomarker determinants associated with the severity of atopic dermatitis.
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.